These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 15150770)
21. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074 [TBL] [Abstract][Full Text] [Related]
22. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital. Rony C; Aharoni S; Halevy A Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604 [TBL] [Abstract][Full Text] [Related]
23. Optic nerve tortuosity in children with neurofibromatosis type 1. Ji J; Shimony J; Gao F; McKinstry RC; Gutmann DH Pediatr Radiol; 2013 Oct; 43(10):1336-43. PubMed ID: 23636538 [TBL] [Abstract][Full Text] [Related]
24. Ophthalmological assessment of children with neurofibromatosis type 1. Cassiman C; Legius E; Spileers W; Casteels I Eur J Pediatr; 2013 Oct; 172(10):1327-33. PubMed ID: 23708214 [TBL] [Abstract][Full Text] [Related]
25. [Optic glioma in children with type 1 neurofibromatosis]. Ben-Arush M; Goldberg H; Kuten A; Guilbord J; el-Hassid R Harefuah; 1998 Oct; 135(7-8):264-7, 336. PubMed ID: 9885670 [TBL] [Abstract][Full Text] [Related]
26. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361 [TBL] [Abstract][Full Text] [Related]
28. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126 [TBL] [Abstract][Full Text] [Related]
29. Comparative study of the ophthalmological examinations in neurofibromatosis type 1. Proposal for a new screening algorithm. Caen S; Cassiman C; Legius E; Casteels I Eur J Paediatr Neurol; 2015 Jul; 19(4):415-22. PubMed ID: 25797697 [TBL] [Abstract][Full Text] [Related]
30. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Thiagalingam S; Flaherty M; Billson F; North K Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338 [TBL] [Abstract][Full Text] [Related]
31. Intraorbital ganglioglioma of optic nerve in a patient with neurofibromatosis type 1. Manojlovic Gacic EM; Skender-Gazibara MK; Gazibara TM; Nagulic MA; Nikolic IM J Neuroophthalmol; 2012 Dec; 32(4):350-3. PubMed ID: 22961113 [TBL] [Abstract][Full Text] [Related]
32. Visual Function, Brain Imaging, and Physiological Factors in Children With Asymmetric Nystagmus due to Chiasmal Gliomas. Estrada M; Kelly JP; Wright J; Phillips JO; Weiss A Pediatr Neurol; 2019 Aug; 97():30-37. PubMed ID: 31113715 [TBL] [Abstract][Full Text] [Related]
33. Neuroophthalmological management of optic pathway gliomas. Lee AG Neurosurg Focus; 2007; 23(5):E1. PubMed ID: 18004957 [TBL] [Abstract][Full Text] [Related]
34. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105 [TBL] [Abstract][Full Text] [Related]
35. Do children with optic pathway tumors have an increased frequency of other central nervous system tumors? Korones DN; Padowski J; Factor BA; Constine LS Neuro Oncol; 2003 Apr; 5(2):116-20. PubMed ID: 12672283 [TBL] [Abstract][Full Text] [Related]
36. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE; Nuding MA Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [TBL] [Abstract][Full Text] [Related]
37. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Rosenfeld A; Listernick R; Charrow J; Goldman S Childs Nerv Syst; 2010 May; 26(5):663-7. PubMed ID: 19937438 [TBL] [Abstract][Full Text] [Related]
38. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Griffiths PD; Blaser S; Mukonoweshuro W; Armstrong D; Milo-Mason G; Cheung S Pediatrics; 1999 Oct; 104(4):e49. PubMed ID: 10506274 [TBL] [Abstract][Full Text] [Related]
39. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice. Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751 [TBL] [Abstract][Full Text] [Related]